Journal
JOURNAL OF NUCLEAR MEDICINE
Volume 53, Issue 8, Pages 1310-1325Publisher
SOC NUCLEAR MEDICINE INC
DOI: 10.2967/jnumed.111.100123
Keywords
MIRD; quantitative SPECT; absorbed dose; 3D dosimetry; patient-specific dosimetry; radionuclide therapy
Funding
- National Institute of Health, U.S. Department of Health and Human Services [R01 EB001994, R01CA109234, R01CA116477]
- Swedish Cancer Foundation
Ask authors/readers for more resources
In internal radionuclide therapy, a growing interest in voxel-level estimates of tissue-absorbed dose has been driven by the desire to report radiobiologic quantities that account for the biologic consequences of both spatial and temporal nonuniformities in these dose estimates. This report presents an overview of 3-dimensional SPECT methods and requirements for internal dosimetry at both regional and voxel levels. Combined SPECT/CT image-based methods are emphasized, because the CT-derived anatomic information allows one to address multiple technical factors that affect SPECT quantification while facilitating the patient-specific voxel-level dosimetry calculation itself. SPECT imaging and reconstruction techniques for quantification in radionuclide therapy are not necessarily the same as those designed to optimize diagnostic imaging quality. The current overview is intended as an introduction to an upcoming series of MIRD pamphlets with detailed radionuclide-specific recommendations intended to provide best-practice SPECT quantification-based guidance for radionuclide dosimetry.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available